QQ客服 官方微博 反馈留言

	HBsAg Loss with Peg-interferon Alfa-2a in Hepatitis B Patients with Partial Response to Nucleoside Analog： New Switch Study
	Peng Hu; Jia Shang; Wenhong Zhang; Guozhong Gong; Yongguo Li; Xinyue Chen; Jianning Jiang; Qing Xie; Xiaoguang Dou; Yongtao Sun
刊名	临床与转化肝病杂志(英文版)
	2018
卷号	第6卷页码:25-34
关键词	Antiviral therapy Peg-interferon Nucleos(t)ide treated Chronic hepatitis B
ISSN号	2225-0719
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/1816530
专题	四川大学
作者单位	1.Hospital of PLA， Beijing， China；Department of Infectious Diseases and Hepatology Unit， Nanfang Hospital， Southern Medical University， Guangzhou， China；Department of Infectious Diseases， The Third Affiliated Hospital of Sun Yat-Sen University， Guangzhou， China；Hepatology Unit， Guangzhou Eighth People's Hospital， Guangzhou， China；Hepatology Unit， Ruian People's Hospital， Zhejiang， China 2.Department of Infectious Diseases， The Second Affiliated Hospital of Chongqing Medical University， Chongqing， China；Department of Infectious Diseases， Henan Provincial People's Hospital， Zhengzhou， China；Department of Infectious Diseases， Huashan Hospital， Fudan University， Shanghai， China；Department of Infectious Diseases， The Second Xiangya Hospital of Central South University， Changsha， China；Department of Infectious Diseases， The First Affiliated Hospital of Harbin Medical University， Harbin， China；International Medical Department， Beijing YouAn Hospital， Capital Medical University， Beijing， China；Department of Infectious Diseases， The First Affiliated Hospital of Guangxi Medical University， Nanning， China；Department of Infectious Diseases， Ruijin Hospital， Shanghai Jiaotong University School of Medicine， Shanghai， China；Department of Infectious Diseases， Shengjing Hospital of China Medical University， Shenyang， China；Department of Infectious Diseases， Tangdu Hospital， Fourth Military Medical University， Xi'an， China；Department of Infectious Diseases， General Hospital of Ningxia Medical University， Yinchuan， China；Department of Infectious Diseases， Shenzhen Third People's Hospital， Shenzhen， China；Department of Infectious Diseases， Xiangya Hospital Central South University， Changsha， China；Liver Disease Department， The First Affiliated Hospital of Guangxi University of Chinese Medicine， Nanning， China；Liver Disease Department， Guangdong Hospital of Traditional Chinese Medicine， Guangzhou， China；Center of Infectious Diseases， West China Hospital， Sichuan University， Chengdu， China；Liver Disease Department， The Sixth People's Hospital of Hangzhou， Zhejiang， China；Liver Disease Department， Beijing Ditan Hospital， Capital Medical University， Beijing， China；Department of Infectious Diseases， Guangdong General Hospital， Guangzhou， China；Center of Liver Diseases， The First Affiliated Hospital of Fujian Medical University， Fuzhou， China；International Center for Liver Disease Treatment，
推荐引用方式 GB/T 7714	Peng Hu,Jia Shang,Wenhong Zhang,等. HBsAg Loss with Peg-interferon Alfa-2a in Hepatitis B Patients with Partial Response to Nucleoside Analog： New Switch Study[J]. 临床与转化肝病杂志(英文版),2018,第6卷:25-34.
APA	Peng Hu.,Jia Shang.,Wenhong Zhang.,Guozhong Gong.,Yongguo Li.,...&Hong Ren.(2018).HBsAg Loss with Peg-interferon Alfa-2a in Hepatitis B Patients with Partial Response to Nucleoside Analog： New Switch Study.临床与转化肝病杂志(英文版),第6卷,25-34.
MLA	Peng Hu,et al."HBsAg Loss with Peg-interferon Alfa-2a in Hepatitis B Patients with Partial Response to Nucleoside Analog： New Switch Study".临床与转化肝病杂志(英文版) 第6卷(2018):25-34.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。